首页> 美国卫生研究院文献>Journal of Medical Case Reports >Fulminant myocarditis induced by immune checkpoint inhibitor nivolumab: a case report and review of the literature

【2h】

Fulminant myocarditis induced by immune checkpoint inhibitor nivolumab: a case report and review of the literature

机译：免疫检查点抑制剂Nivolumab诱导的暴发性心肌炎：案例报告和对文献的审查

代理获取

本网站仅为用户提供外文OA文献查询和代理获取服务，本网站没有原文。下单后我们将采用程序或人工为您竭诚获取高质量的原文，但由于OA文献来源多样且变更频繁，仍可能出现获取不到、文献不完整或与标题不符等情况，如果获取不到我们将提供退款服务。请知悉。

页面导航

摘要
著录项
相似文献
相关主题

摘要

Timeline of NT-proBNP, CK-MB, and troponin T levels during hospitalization. The dotted line indicates the application time of CPR and ECMO. ECMO extracorporeal membrane oxygenation, CPR cardiopulmonary resuscitation

机译：NT-probnp，CK-MB和肌霉素T级的时间表在住院期间。虚线表示CPR和ECMO的应用时间。 ECMO体外膜氧合，CPR心肺复苏

著录项

期刊名称 Journal of Medical Case Reports
作者
Feifei Wang; Yang Liu; Wei Xu; Changjing Zhang; Jianhong Lv; Shaolin Ma;
展开▼
作者单位

展开▼
年(卷),期 2021(-1),-1
年度 2021
页码 -1
总页数 5
原文格式 PDF
正文语种
中图分类
关键词

机译：Nivolimab;Anahibitor中的免疫检查点;暴发性心肌炎;Ecmo;

相似文献

外文文献
中文文献
专利

1. Late-Onset Fulminant Myocarditis With Immune Checkpoint Inhibitor Nivolumab [J] . Yamaguchi Shogo, Morimoto Ryota, Okumura Takahiro, The Canadian journal of cardiology . 2018,第6期

机译：具有免疫检查点抑制剂Nivolumab的晚期发病漏氨体心肌炎
2. Cardiac toxicity of immune-checkpoint inhibitors: a clinical case of nivolumab-induced myocarditis and review of the evidence and new challenges [J] . Roberto Martin Huertas, Cristina Saavedra Serrano, Cristian Perna, Cancer Management and Research . 2019,第2016期

机译：免疫检查点抑制剂的心脏毒性：Nivolumab诱发的心肌炎的临床案例以及证据和新挑战的回顾
3. Cardiac toxicity of immune-checkpoint inhibitors: a clinical case of nivolumab-induced myocarditis and review of the evidence and new challenges [J] . Roberto Martin Huertas, Cristina Saavedra Serrano, Cristian Perna, Cancer Management and Research . 2019,第1期

机译：免疫检查点抑制剂的心脏毒性：Nivolumab诱发的心肌炎的临床案例以及证据和新挑战的回顾
4. Molecular dynamics of the immune checkpoint Programmed Cell Death Protein I, PD-1: Conformational changes of the BC-loop upon binding of the ligand PD-L1 and the monoclonal antibody nivolumab [C] . Bernhard Roither, Chris Oostenbrink, Wolfgang Schreiner IEEE International Conference on Bioinformatics and Biomedicine . 2019

机译：免疫检查点的分子动力学程序性细胞死亡蛋白I，PD-1：配体PD-L1与单克隆抗体nivolumab结合后BC环的构象变化
5. Immune-Related Adverse Events in Cancer Patients Being Treated with Immune Checkpoint Inhibitors [D] . Byrne, Margaret M. 2021

机译：用免疫检查点抑制剂治疗癌症患者免疫相关不良事件
6. Cardiac toxicity of immune-checkpoint inhibitors: a clinical case of nivolumab-induced myocarditis and review of the evidence and new challenges [O] . Roberto Martin Huertas, Cristina Saavedra Serrano, Cristian Perna, 2019

机译：免疫检查点抑制剂的心脏毒性：Nivolumab诱发的心肌炎的临床案例以及证据和新挑战的回顾
7. >Cardiac toxicity of immune-checkpoint inhibitors: a clinical case of nivolumab-induced myocarditis and review of the evidence and new challenges [O] . Roberto Martin Huertas, Cristina Saavedra Serrano, Cristian Perna, 2019

机译：>免疫检查点抑制剂的心脏毒性：Nivolumab诱导的心肌炎的临床病例，以及对证据和新挑战的审查

Fulminant myocarditis induced by immune checkpoint inhibitor nivolumab: a case report and review of the literature

摘要

著录项

相似文献

相关主题

期刊订阅